Document is current
Any future updates will be listed below
-
Authors
Mizutani, Ryuta https://orcid.org/0000-0002-5484-4861
Saiga, Rino https://orcid.org/0000-0001-7427-7764
Yamamoto, Yoshiro https://orcid.org/0000-0002-9067-1208
Uesugi, Masayuki https://orcid.org/0000-0001-6261-9034
Takeuchi, Akihisa https://orcid.org/0000-0001-7693-9928
Uesugi, Kentaro https://orcid.org/0000-0003-2579-513X
Terada, Yasuko
Suzuki, Yoshio
De Andrade, Vincent https://orcid.org/0000-0003-0987-6618
De Carlo, Francesco https://orcid.org/0000-0003-1068-7785
Takekoshi, Susumu https://orcid.org/0000-0001-8815-8643
Inomoto, Chie
Nakamura, Naoya https://orcid.org/0000-0003-4332-5254
Torii, Youta
Kushima, Itaru https://orcid.org/0000-0002-0018-5178
Iritani, Shuji https://orcid.org/0000-0002-4588-4474
Ozaki, Norio https://orcid.org/0000-0002-7360-4898
Oshima, Kenichi
Itokawa, Masanari https://orcid.org/0000-0003-4433-8030
Arai, Makoto https://orcid.org/0000-0003-3400-9815
-
Funding
Funding for this research was provided by:
MEXT | Japan Society for the Promotion of Science (21611009)
MEXT | Japan Society for the Promotion of Science (25282250)
MEXT | Japan Society for the Promotion of Science (25610126)
MEXT | Japan Society for the Promotion of Science (18H04040)
Japan Agency for Medical Research and Development (19dm0107108)
Japan Agency for Medical Research and Development (JP18dm0107087)
Japan Agency for Medical Research and Development (JP19dm0107087)
Japan Agency for Medical Research and Development (JP20dm0107087)
Japan Agency for Medical Research and Development (JP20dm0207075)
Japan Agency for Medical Research and Development (JP20dk0307081)
Japan Agency for Medical Research and Development (JP18dm0107088)
Japan Agency for Medical Research and Development (JP19dm0107088h0004)
Japan Agency for Medical Research and Development (JP20dm0107088h0005)
- License Information
-
More Information
Article History
Received: 9 September 2020
Revised: 7 December 2020
Accepted: 15 December 2020
First Online: 14 January 2021
Conflict of interest
: M.I. and M.A. declare a conflict of interest, being authors of several patents regarding therapeutic use of pyridoxamine for schizophrenia. All other authors declare no conflict of interest.
